US HB6501 | 2015-2016 | 114th Congress

Status

Spectrum: Partisan Bill (Democrat 9-0)
Status: Introduced on December 8 2016 - 25% progression, died in committee
Action: 2016-12-22 - Referred to the Subcommittee on Courts, Intellectual Property, and the Internet.
Pending: House Subcommittee on Courts, Intellectual Property, And The Internet Committee
Text: Latest bill text (Introduced) [PDF]

Summary

Prescription Drug and Medical Device Price Review Board Act of 2016

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Prescription Drug and Medical Device Price Review Board Act of 2016

Sponsors


History

DateChamberAction
2016-12-22HouseReferred to the Subcommittee on Courts, Intellectual Property, and the Internet.
2016-12-08HouseReferred to House Judiciary
2016-12-08HouseReferred to House Ways and Means
2016-12-08HouseReferred to House Energy and Commerce
2016-12-08HouseReferred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2016-12-08HouseIntroduced in House

US Congress State Sources


Bill Comments

feedback